Brief: Genscript Biotech Says Legend Biotech Regained Compliance With Nasdaq Listing Rule
21/02/2023 14:36
Feb 21 (Reuters) - Genscript Biotech Corp 1548.HK :
* LEGEND BIOTECH GOT NOTICE ON 17 FEB INDICATING IT REGAINED
COMPLIANCE WITH NASDAQ LISTING RULE
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale